type here...

CATEGORIES

Healthcare

LATEST

1...424344...75Page 43 of 75

TRENDING

EDITORS CHOICE

The Battle Against An Ignoble Death

Dr. Hesham A. Hassaballa -
The battle against critical illness in the ICU is self-evident. The battle against an ignoble death is paramount for me.

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

James Coyne -
The largest number of authors (12) are with MAPS. The for-profit corporation will manage sales for prescription MDMA when it is approved by the FDA

Primary Care for the Sickest of the Sick

Stephen Schimpff, MD MACP -
Comprehensive Care Improves Health Yet Reduces Total Costs

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories